AC-20-SO29_1uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=1uM, Fluvoxamine, 5-HT Reuptake Inhibitors targeting SLC6A4 (Novartis, 5324346)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/5324346
Similar Terms
Downloads & Tools

Genes

20 genes differentially expressed following the AC-20-SO29_1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
CCT7 chaperonin containing TCP1, subunit 7 (eta) 0.826629
BLVRB biliverdin reductase B 0.439974
ABHD14B abhydrolase domain containing 14B 0.269328
RPS9 ribosomal protein S9 0.236949
FAU Finkel-Biskis-Reilly murine sarcoma virus (FBR-MuSV) ubiquitously expressed 0.236374
MRPL57 mitochondrial ribosomal protein L57 0.236374
RPS5 ribosomal protein S5 0.229782
MAPK12 mitogen-activated protein kinase 12 0.221645
NDUFA11 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 11, 14.7kDa 0.219389
TRAPPC2L trafficking protein particle complex 2-like 0.206356
RPS15 ribosomal protein S15 0.201954

decreased expression

Symbol Name Standardized Value
GTPBP3 GTP binding protein 3 (mitochondrial) -0.771862
ZNF496 zinc finger protein 496 -0.312453
KANK2 KN motif and ankyrin repeat domains 2 -0.258161
BUB1 BUB1 mitotic checkpoint serine/threonine kinase -0.236374
NIN ninein (GSK3B interacting protein) -0.236374
MICAL2 microtubule associated monooxygenase, calponin and LIM domain containing 2 -0.232752
YBX3 Y box binding protein 3 -0.231269
HNRNPA2B1 heterogeneous nuclear ribonucleoprotein A2/B1 -0.229782
RFX4 regulatory factor X, 4 (influences HLA class II expression) -0.206356